Engineered AAV Vectors for CNS Endothelial Targeting
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current AAV vectors are limited in their ability to specifically target and efficiently transduce CNS endothelial cells, which are crucial for neurovascular research and disease studies, due to a lack of effective tools for studying these cells in vivo.
Innovation Solution
Development of engineered AAV vectors with a targeting moiety, such as the n-mer motif, that enhances transduction efficiency in CNS vascular endothelial cells by incorporating specific amino acid sequences into the viral capsid protein, allowing for preferential delivery of cargo to endothelial cells in the CNS vasculature.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If conventional AAV vectors are used, then general transduction capability is maintained, but endothelial cell-specific transduction efficiency is insufficient
Solution Approach 1:
The patent applies local quality by engineering specific amino acid sequences (n-mer motifs) at particular locations within the AAV capsid protein structure. These localized modifications at specific capsid positions enable endothelial cell targeting without altering the overall vector architecture, thereby improving transduction efficiency while maintaining manageable design complexity
Solution Approach 2:
The patent employs parameter changes by systematically varying amino acid sequences (n-mer motifs) at specific positions in the capsid protein. By optimizing parameters such as amino acid composition, charge distribution, and sequence length, the invention achieves enhanced endothelial targeting capability while keeping the vector design within feasible manufacturing parameters
2Manufacturing precision
If AAV vectors are engineered with targeting moieties, then transduction specificity for CNS endothelial cells is improved, but vector structural complexity increases
Solution Approach 1:
The invention implements local quality by introducing targeted amino acid modifications at specific regions of the capsid protein rather than throughout the entire structure. This localized approach achieves high targeting specificity for CNS endothelial cells while minimizing overall structural complexity and maintaining capsid stability
Solution Approach 2:
The patent applies segmentation by dividing the capsid modification strategy into discrete n-mer motif units that can be independently designed and tested. This modular approach allows for systematic optimization of targeting specificity while keeping individual modification elements simple and manageable
Data Source
AI summary
Highly selective targeting moieties and compositions comprising the targeting moieties are described herein to efficiently transduce endothelial cell of the central nervous system vasculature. Embodiments include use and delivery of the targeting moieties and compositions to selectively direct delivery of cargo.